Connection

Toru Hifumi to Hypnotics and Sedatives

Back to Details
This is a "connection" page, showing publications Toru Hifumi has written about Hypnotics and Sedatives.
Toru Hifumi
Connection Strength
0.323
Hypnotics and Sedatives
  1. Neuroleptic malignant syndrome in patients with COVID-19. Am J Emerg Med. 2020 10; 38(10):2243.e1-2243.e3.
    View in: PubMed
    Score: 0.138
  2. Association between dexmedetomidine use and neurological outcomes in aneurysmal subarachnoid hemorrhage patients: A retrospective observational study. J Crit Care. 2018 04; 44:111-116.
    View in: PubMed
    Score: 0.115
  3. The authors' response: Propofol in COVID 19: From basic science to clinical impact. Am J Emerg Med. 2021 07; 45:528.
    View in: PubMed
    Score: 0.035
  4. The authors' response: Propofol and sedation in patients with coronavirus disease 2019. Am J Emerg Med. 2021 Apr; 42:251.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.